Clinical effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: the CoBalT randomised controlled trial

Clinical effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: the CoBalT randomised controlled trial

Background: Only one-third of patients with depression respond fully to treatment with antidepressant medication. However, there is little robust evidence to guide the management of those whose symptoms are ‘treatment resistant’. Objective: The CoBalT trial examined the clinical effectiveness and co...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser: Nicola Wiles, Laura Thomas, Anna Abel, Maria Barnes, Fran Carroll, Nicola Ridgway, Sofie Sherlock, Nicholas Turner, Katherine Button, Lang’o Odondi, Chris Metcalfe, Amanda Owen-Smith, John Campbell, Anne Garland, Sandra Hollinghurst, Bill Jerrom, David Kessler, Willem Kuyken, Jill Morrison, Katrina Turner, Chris Williams, Tim Peters, Glyn Lewis
Format: Artikel
Sprache:English
Veröffentlicht: NIHR Journals Library 2014-05-01
Schriftenreihe:Health Technology Assessment
Schlagworte:
clinical effectiveness
cost-effectiveness
cognitive–behavioural therapy
adjunct pharmacotherapy
treatment-resistant depression
primary care
cobalt
randomised controlled trial
Online Zugang:https://doi.org/10.3310/hta18310

Online

https://doi.org/10.3310/hta18310

Ähnliche Einträge